NeoGlyco Therapeutics
Biotechnology Research
Pleasanton, California, United States
6 employees
- Employees
- 6
NeoGlyco Therapeutics Overview
- Headquarters
- Pleasanton, California, United States
- Website
- neoglyco.com
- Industry
- Biotechnology Research
- Employees
- 6
- Founded
- 2024
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About NeoGlyco Therapeutics
NeoGlyco Therapeutics is a cutting-edge start-up, leading the development of new generation novel anti-cancer antibodies using our advanced custom phage library. Our Dual Specificity Antibodies target a specific part of a cancer cell protein that includes two key features. This innovation could lead many potential markers with significant clinical benefits to become successful antibody targets, and reducing or even eliminating harmful side effects.
Compare Similar Companies to NeoGlyco Therapeutics
Stealth AI Startup
Technology, Information And Internet
Unreasonable
Venture Capital And Private Equity Principals
Eurofins Nutrition Analysis Center (ENAC)
Biotechnology Research
TurtleTree
Biotechnology Research
Norton Hospitality Group
Hospitality
Shona Prince Technologies
Technology, Information And Internet
TW1 Healthcare Consulting
Business Consulting And Services
FNL Institute
Research Services
MO Batteries Singapore Pte Ltd
Motor Vehicle Manufacturing
iCare Singapore
Retail